- Filed
- Mar 9, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 6, 2026 | 26.35M sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 26.34M sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 26.34M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 26.35M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 26.35M sh |
| Stock Repurchased | Q3 2025 · Sep 27, 2025 | $85K |
| Stock Repurchased | Q3 2025 · Sep 28, 2024 | $83K |
| Dividends Paid | Q3 2025 · Sep 27, 2025 | $8.29M |
| Dividends Paid | Q3 2025 · Sep 28, 2024 | $8.29M |
| Capex | Q3 2025 · Sep 27, 2025 | $191.32M |
| Capex | Q3 2025 · Sep 28, 2024 | $210.81M |
| Operating Cash Flow | Q3 2025 · Sep 27, 2025 | $135.92M |
| Operating Cash Flow | Q3 2025 · Sep 28, 2024 | $52.63M |
| Long Term Debt | Q3 2025 · Sep 27, 2025 | $718.95M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $670.27M |
| Short Term Debt | Q3 2025 · Sep 27, 2025 | $105.23M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $88.81M |
| Cash And Equivalents | Q3 2025 · Sep 27, 2025 | $27.38M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $19.35M |
| Stockholders Equity restated | Q3 2025 · Sep 27, 2025 | $534.91M |
| Stockholders Equity | Q3 2025 · Jun 28, 2025 | $653.69M |
| Stockholders Equity | Q3 2025 · Mar 29, 2025 | $646.4M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $647.02M |
| Stockholders Equity | Q3 2025 · Sep 28, 2024 | $630.98M |
| Stockholders Equity | Q3 2025 · Jun 29, 2024 | $608.9M |
| Stockholders Equity | Q3 2025 · Mar 30, 2024 | $583.95M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $532.2M |
| Current Liabilities | Q3 2025 · Sep 27, 2025 | $324.27M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $304.57M |
| Current Assets | Q3 2025 · Sep 27, 2025 | $429.01M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $409.81M |
| Total Assets restated | Q3 2025 · Sep 27, 2025 | $1.77B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $1.79B |
| Eps Diluted restated | Q3 2025 · Sep 27, 2025 | −$4.48 |
| Eps Diluted restated | Q3 2025 · Sep 27, 2025 | −$3.93 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | $1.01 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | $4.17 |
| Eps Basic restated | Q3 2025 · Sep 27, 2025 | −$4.48 |
| Eps Basic restated | Q3 2025 · Sep 27, 2025 | −$3.94 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | $1.01 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | $4.17 |
| Net Income restated | Q3 2025 · Sep 27, 2025 | −$117.94M |
| Net Income restated | Q3 2025 · Sep 27, 2025 | −$103.61M |
| Net Income | Q3 2025 · Jun 28, 2025 | $8.32M |
| Net Income | Q3 2025 · Mar 29, 2025 | $6.01M |
| Net Income | Q3 2025 · Sep 28, 2024 | $26.54M |
| Net Income | Q3 2025 · Sep 28, 2024 | $109.73M |
| Net Income | Q3 2025 · Jun 29, 2024 | $30.73M |
| Net Income | Q3 2025 · Mar 30, 2024 | $52.46M |
| Operating Income restated | Q3 2025 · Sep 27, 2025 | −$117.41M |
| Operating Income restated | Q3 2025 · Sep 27, 2025 | −$81.84M |
| Operating Income | Q3 2025 · Sep 28, 2024 | $42.63M |
| Operating Income | Q3 2025 · Sep 28, 2024 | $164.83M |
| Revenue | Q3 2025 · Sep 27, 2025 | $396.79M |
| Revenue | Q3 2025 · Sep 27, 2025 | $1.17B |
| Revenue | Q3 2025 · Sep 28, 2024 | $426.83M |
| Revenue | Q3 2025 · Sep 28, 2024 | $1.38B |